Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV)

Virology. 2003 Mar 30;308(1):37-47. doi: 10.1016/s0042-6822(02)00046-6.

Abstract

Passage of the prototypic arenavirus lymphocytic choriomenigitis virus (LCMV) in cultured cells in the presence of the mutagenic agent 5-fluorouracil (FU) resulted in efficient and systematic virus extinction under conditions that did not significantly affect cell survival. FU-mediated extinction of LCMV was associated with 3.6- to 10-fold increases in the mutation frequencies for the three viral genes examined, but with only very modest effects on virus replication and transcription during a single round of infection. Likewise, FU did not affect expression of a LCMV minigenome. In contrast, the well documented antiviral effect of ribavirin against LCMV was not associated with significant increases in virus mutation frequencies, but rather with a dramatic inhibition of both viral RNA synthesis and LCMV minigenome expression. Mutagen induced viral extinction has been recently reported for positive strand RNA viruses polio and foot-and-mouth disease, and the lentivirus HIV-1. Our findings indicate that lethal mutagenesis can be effective also against LCMV, a negative strand RNA virus. Moreover, FU treatment prevented the establishment of LCMV persistent infection in mice deficient in B and T cells, suggesting the feasibility in vivo of lethal mutagenesis as a novel antiviral strategy.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antiviral Agents / pharmacology*
  • Arenaviridae Infections / drug therapy
  • Arenaviridae Infections / immunology
  • Arenaviridae Infections / virology*
  • B-Lymphocytes / immunology
  • Cell Line
  • Cricetinae
  • DNA-Binding Proteins / deficiency
  • Fluorouracil / pharmacology*
  • Gene Expression / drug effects
  • Lymphocytic choriomeningitis virus / drug effects*
  • Lymphocytic choriomeningitis virus / genetics
  • Lymphocytic choriomeningitis virus / pathogenicity
  • Mice
  • Mice, Knockout
  • Mutagenesis / drug effects*
  • RNA, Viral / analysis
  • RNA, Viral / biosynthesis
  • Receptors, Interferon / deficiency
  • Ribavirin / pharmacology
  • T-Lymphocytes / immunology
  • Transfection
  • Virus Replication / drug effects

Substances

  • Antiviral Agents
  • DNA-Binding Proteins
  • RNA, Viral
  • Rag2 protein, mouse
  • Receptors, Interferon
  • V(D)J recombination activating protein 2
  • Ribavirin
  • Fluorouracil